Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > keep pumping this dog sh**T

<< Previous

Bullboard Posts

Next >>

Comment by TitanBrawleron Dec 19, 2022 10:30pm

162 Views

Post# 35181284

RE:keep pumping this dog sh**T

All jokes aside...
I feel for you Canadianfan, I honestly do.
You said you have a great deal of money invested in ONC.
I know it's a hard pill to swallow,
but ..I hope for your sake it goes up to a point where you can make some profit or atleast break even.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China